Form 4: UnitedHealth Group Director Acquires Shares as Part of Compensation Plan

John H. Noseworthy, a director at UnitedHealth Group, acquired 190 shares of common stock on July 1, 2024, as part of his director compensation.

Summary

• On July 1, 2024, John H. Noseworthy, a director of UnitedHealth Group, acquired 190 shares of the company's common stock.
• The acquisition was part of his regular quarterly compensation for serving as a director.
• These shares are in the form of deferred stock units, which are immediately vested but must be retained until his service on the Board is complete.
• The price of the stock at the time of acquisition was $0.
• Following the transaction, Noseworthy directly owns 5,169 shares of UnitedHealth Group common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and well-managed company. The sentiment is neutral to positive.

Positives

• The acquisition of shares by a director demonstrates alignment with shareholder interests.
• The structure of deferred stock units incentivizes long-term commitment to the company.

Industry Context

Director share acquisitions are a common practice in publicly traded companies to align management and shareholder interests. This transaction is a routine part of UnitedHealth Group's director compensation plan.

Comparison to Industry Standards

• Director compensation packages often include stock options, restricted stock units, or deferred stock units to incentivize long-term performance.
• Companies like Johnson & Johnson (JNJ) and Pfizer (PFE) also utilize similar equity-based compensation for their directors.
• The vesting and retention requirements for these equity grants vary, but the general principle of aligning director interests with shareholder value is consistent across the industry.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder confidence.
• The compensation structure incentivizes the director to act in the best long-term interests of the company and its stakeholders.

Key Dates